Updated FDA regulations for the use of Testosterone
2026 · 2nd Quarter (Apr 1 - June 30)
SYNGENERX HEALTH
Filed by ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP).
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Aug 3, 2026
- Income
- $42,500.00
- Expenses
- Not reported
- Client
- SYNGENERX HEALTH
- Filing UUID
- e1737524-3bc1-411f-92fa-8b44febc912d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Updated FDA regulation around the use of Testosterone
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.